Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Sustainable Development Goals
05 Igualdade de gêneroCollections
- BA - IGM - Artigos de Periódicos [3814]
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
SEX-RELATED DIFFERENCES IN INFLAMMATORY AND IMMUNE ACTIVATION MARKERS BEFORE AND AFTER COMBINED ANTIRETROVIRAL THERAPY INITIATION
https://www.arca.fiocruz.br/handle/icict/65937
Author
Affilliation
Abstract
Background: Women progress to death at the same rate as men despite lower plasma HIV RNA (viral load). We investigated sex-specific differences in immune activation and inflammation as a potential explanation. Methods: Inflammatory and immune activation markers [interferon g, tumor necrosis factor (TNF) a, IL-6, IL-18, IFN-g–induced protein 10, C-reactive protein (CRP), lipopolysaccharide, and sCD14] were measured at weeks 0, 24, and 48 after combination antiretroviral therapy (cART) in a random subcohort (n = 215) who achieved virologic suppression in ACTG A5175 (Prospective Evaluation of Antiretrovirals in Resource-Limited Settings). Association between sex and changes in markers postcART was examined using random effects models. Average marker differences and 95% confidence intervals were estimated using multivariable models. Results: At baseline, women had lower median log10 viral load (4.93 vs 5.18 copies per milliliter, P = 0.01), CRP (2.32 vs 4.62 mg/L, P =0.01), detectable lipopolysaccharide (39% vs 55%, P = 0.04), and sCD14 (1.9 vs 2.3 mg/mL, P = 0.06) vs men. By week 48, women had higher interferon g (22.4 vs 14.9 pg/mL, P = 0.05), TNF-a (11.5 vs 9.5pg/mL, P = 0.02), and CD4 (373 vs 323 cells per cubic millimeter, P =0.02). In multivariate analysis, women had greater increases in CD4 and TNF-a but less of a decrease in CRP and sCD14 compared with men. Conclusions: With cART-induced viral suppression, women have less reduction in key markers of inflammation and immune activation compared with men. Future studies should investigate the impact of these sex-specific differences on morbidity and mortality.
Share